flourishresearch.com

Case Studies

Participant Diversity

With 52% of our participant database and 62% of our employees self-identifying as belonging to underrepresented communities, we consistently exceed our clients’ diversity goals.

Overview

  • Recent phase 1 study enrolled 52% Hispanics, 27% African Americans, 3% Native Americans
  • COVID-19 vaccine: 55% over the age of 60, 78% Hispanics. All of our sites over-enrolled, randomizing on average 326% of the goal
  • Recent vaccine study for participants 65 and older enrolled 34% Hispanics
  • Flu studies: over 50% of participants 60 and older, more than 1,400 patients enrolled

Selected to participate in an American Heart Association sponsored study to examine methods to increase diversity in clinical trials with Stanford University School of Medicine/Morehouse School of Medicine

Diversity
52%
diverse patients
Flourish Research News

Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.

Exciting News! ENCORE™ is now part of the Flourish family!